Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2000
04/20/2000CA2347113A1 Human ankyrin family protein
04/20/2000CA2346943A1 Cyclic tetrapeptide compound and use thereof
04/20/2000CA2346775A1 Protein kinase homologs
04/20/2000CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity
04/20/2000CA2346464A1 Peripherally acting anti-pruritic opiates
04/20/2000CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses
04/20/2000CA2346155A1 Enzymatic synthesis of ssdna
04/20/2000CA2346038A1 Methods for inhibiting bone resorption
04/20/2000CA2346036A1 Methods for regulating bone formation
04/20/2000CA2346006A1 Delta 6 fatty acid desaturase
04/20/2000CA2344694A1 Benzazine derivatives as phosphodiesterase 4 inhibitors
04/20/2000CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth
04/19/2000EP0994119A1 Stereoselective process for the preparation of the 22R epimer of budesonide
04/19/2000EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
04/19/2000EP0993456A1 2-substituted 4,5-diaryl imidazoles
04/19/2000EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors
04/19/2000EP0993442A1 Hydrazine derivatives
04/19/2000EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
04/19/2000EP0738262B1 Novel heterocyclic compounds
04/19/2000CN1251134A Neurotrophic factor NNT-1
04/19/2000CN1251092A Certain cyclic thio substitued acylaminoacid amide derivatives
04/19/2000CN1250776A Heterodicyclic compound derivatives
04/19/2000CN1250664A Chinese medicine for treating gout
04/19/2000CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof
04/18/2000US6051718 A phosphodiesterase enzyme inhibitor and a cytokine antagonist for treating allergic, atopic and inflammatory diseases inflammatory diseases
04/18/2000US6051601 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
04/18/2000US6051571 Methods for treating medical dysfunctions and diseases using furan nitrone compounds
04/18/2000US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
04/18/2000US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents
04/18/2000US6051228 Antibodies against human CD40
04/13/2000WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION
04/13/2000WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION
04/13/2000WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof
04/13/2000WO2000020612A2 Therapeutically active proteins in plants
04/13/2000WO2000020590A2 G-protein coupled receptor proteins
04/13/2000WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000WO2000020453A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
04/13/2000WO2000020450A2 Calcium channel alpha-2/delta gene
04/13/2000WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
04/13/2000WO2000020444A1 Novel peptides
04/13/2000WO2000020443A1 Novel peptides
04/13/2000WO2000020435A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs)
04/13/2000WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000WO2000020402A1 Chemical compounds
04/13/2000WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands
04/13/2000WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
04/13/2000WO2000020396A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins
04/13/2000WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use
04/13/2000WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
04/13/2000WO2000020371A1 Prostaglandin receptor ligands
04/13/2000WO2000020030A1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies
04/13/2000WO2000020013A1 Reduction of oxidative stress factors
04/13/2000WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000WO2000020001A1 Mglur5 antagonists for the treatment of pain and anxiety
04/13/2000WO2000020000A1 Controlled release oral preparations of esculetin and its derivatives
04/13/2000WO2000019999A1 Fulvic acid and its use in the treatment of various conditions
04/13/2000WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
04/13/2000WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
04/13/2000WO2000019987A1 Mucosal originated drug delivery systems and animal applications
04/13/2000WO2000019976A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
04/13/2000WO2000002877A3 New pharmaceutically active compounds
04/13/2000WO2000001415A3 Use of inhibitors of protein kinase c epsilon to treat pain
04/13/2000CA2346496A1 Novel th2-specific molecules and uses thereof
04/13/2000CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands
04/13/2000CA2346443A1 Prostaglandin receptor ligands
04/13/2000CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
04/13/2000CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
04/13/2000CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof
04/13/2000CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
04/13/2000CA2345808A1 Mucosal originated drug delivery systems and animal applications
04/13/2000CA2345377A1 Novel secreted proteins and polynucleotides encoding them
04/13/2000CA2345375A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
04/13/2000CA2345240A1 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
04/13/2000CA2345209A1 Antisense modulation of integrin .alpha.4 expression
04/13/2000CA2345137A1 Mglur5 antagonists for the treatment of pain and anxiety
04/13/2000CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2345110A1 Reduction of oxidative stress factors
04/13/2000CA2345045A1 G-protein coupled receptor proteins
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2344765A1 Novel peptides
04/13/2000CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression
04/13/2000CA2344551A1 P-conotoxin peptide
04/13/2000CA2344269A1 Therapeutically active proteins in plants
04/13/2000CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/13/2000CA2341351A1 Alpha-2/delta gene
04/12/2000EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists
04/12/2000EP0991758A1 Smad6 and uses thereof
04/12/2000EP0991753A1 Protease inhibitors
04/12/2000EP0991665A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991659A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991653A1 Novel compounds
04/12/2000EP0991650A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
04/12/2000EP0991630A1 Crystalline roxifiban
04/12/2000EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES
04/12/2000EP0991622A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents
04/12/2000EP0991420A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
1 ... 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 ... 1272